Current position:Home >Product >
Thiazolidine,3-[(2S,3S)-2-aMino-3-Methyl-1-oxopentyl]-, (2E)-2-butenedioate (2:1)
Thiazolidine,3-[(2S,3S)-2-aMino-3-Methyl-1-oxopentyl]-, (2E)-2-butenedioate (2:1)(251572-86-8)
- Name: Thiazolidine,3-[(2S,3S)-2-aMino-3-Methyl-1-oxopentyl]-, (2E)-2-butenedioate (2:1)
- Synonyms:
- Molecular Formula:C9H18N2OS.1/2C4H4O4
- Molecular Weight:520.70600
- CAS Registry Number:251572-86-8
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.251572-86-8 (2S,3S)-2-amino-3-methyl-1-(thiazolidin-3-yl)pentan-1-one hemifumarate
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.251572-86-8 Thiazolidine,3-[(2S,3S)-2-aMino-3-Methyl-1-oxopentyl]-, (2E)-2-butenedioate (2:1)
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:Thiazolidine,3-[(2S,3S)-2-aMino-3-Methyl-1-oxopentyl]-, (2E)-2-butenedioate (2:1)
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.251572-86-8 P32/98 hemifumarate
Assay:鈮?8% Appearance:Crystalline Solid Application:research use
Min. Order:1Gram
Supplier:BOC Sciences [
United States]
Other Product
- 2515-60-8/1H-Pyrazole, 5-(4-bromophenyl)-4,5-dihydro-1,3-diphenyl-
- 2515-61-9/1H-Pyrazole, 4,5-dihydro-1,5-diphenyl-
- 251562-06-8/Methanone, [3,4-dihydro-3,3-dimethyl-8-[(phenylmethyl)amino]-2H-1,4-benzoxazin-5 -yl]phenyl-
- 251562-07-9/Methanone, [3,4-dihydro-3,3-dimethyl-8-[(3-methylbutyl)amino]-2H-1,4-benzoxazin-5 -yl]phenyl-
- 251562-08-0/Methanone, [3,4-dihydro-8-[(2-hydroxyethyl)amino]-3,3-dimethyl-2H-1,4-benzoxazin- 5-yl]phenyl-
- 251562-09-1/Methanone, [3,4-dihydro-8-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-3,3-dimethyl-2 H-1,4-benzoxazin-5-yl]phenyl-
- 251562-63-7/2H-1-Benzopyran-6-ol, 3,4-dihydro-2,8-dimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-, (2R)-rel-
- 251566-01-5/1,3,2-Dioxaborolane, 2-[4-[(2-ethylhexyl)oxy]phenyl]-4,4,5,5-tetramethyl-
- 251568-85-1/2,1,3-Benzoxadiazole-5-carboxylic acid, monooxide
- 251568-94-2/Morpholine, 4-[(oxido-2,1,3-benzoxadiazol-5-yl)carbonyl]-
- 251570-11-3/Hydrazinecarbothioamide, 2,2'-(1-phenyl-1,2-ethanediylidene)bis[N-ethyl-
- 251570-72-6/2-Propenoic acid, 3-[4-(phenylacetyl)phenyl]-
- 251570-79-3/2-Propenoic acid, 3-[4-[1-oxo-2-(pentafluorophenyl)-2-propenyl]phenyl]-
- 251570-82-8/2-Propenoic acid, 3-[4-(1-oxo-2-phenyl-2-propenyl)phenyl]-
- 251571-11-6/4-Thiazolidinone, 2-(3,4-dimethylphenyl)-3-[2-(4-methoxyphenyl)ethyl]-
- 251571-76-3/Thiazolidine, 3-[(2S)-2-pyrrolidinylcarbonyl]-
- 251571-80-9/Thiazolidine, 3-[(2S,3R)-2-amino-3-methyl-1-oxopentyl]-
- 251572-86-8/Thiazolidine,3-[(2S,3S)-2-aMino-3-Methyl-1-oxopentyl]-, (2E)-2-butenedioate (2:1)
- 251575-48-1/Acetic acid, [[(2-iodophenyl)methyl]oxidoimino]-
- 251575-49-2/Acetic acid, [[(3-iodophenyl)methyl]oxidoimino]-
- 251577-09-0/L-Methionine, N-[[5-[[(1H-imidazol-4-ylmethyl)amino]methyl]-2'-methyl[1,1'-biphenyl]-2- yl]carbonyl]-
- 251577-10-3/L-Leucine, N-[[5-[(1H-imidazol-4-ylmethyl)amino]-2'-methyl[1,1'-biphenyl]-2-yl]carb onyl]-
- 251580-01-5/L-Prolinamide, N-acetyl-N-methylglycylglycyl-L-valyl-D-isoleucyl-L-threonyl-L-glutaminyl-L- isoleucyl-L-arginyl-N-ethyl-
- 25158-36-5/2-Anthracenesulfonic acid, 1-amino-3-bromo-9,10-dihydro-9,10-dioxo-
- 25158-78-5/3-(4-BROMOPHENYL)CYCLOHEXANONE
- 251-59-2/1H-Pyrrolizine
- 25160-69-4/Thiourea, N-butyl-N'-1-naphthalenyl-
- 25160-76-3/Acetic acid, dinitro-, methyl ester (6CI,7CI,8CI,9CI)
- 2516-14-5/1,2-Cyclopropanedicarboxamide, trans-
- 2516-22-5/Benzene, [1-(2-phenylethoxy)ethyl]-